butabarbital decreases effects of hemin by pharmacodynamic antagonism. Use Caution/Monitor. Medicine that increase delta-aminolevulinic acid synthetase may well reduce hemin effect.
Always speak to your healthcare service provider to make certain the knowledge shown on this site relates to your individual circumstances.
butabarbital will decrease the level or result of eltrombopag by impacting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Monitor.
butabarbital will lower the level or outcome of ramelteon by influencing hepatic enzyme CYP2C9/ten metabolism. Slight/Significance Unidentified.
Primidone: May boost the adverse/toxic impact of Barbiturates. Primidone is converted to phenobarbital, and therefore results in being additive with current barbiturate therapy. Watch therapy
butabarbital will reduce the extent or effect of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
butabarbital will lower the level or outcome of ziprasidone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Not known.
butabarbital will lessen the extent or outcome of sunitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
butabarbital will lessen the extent or impact of fruquintinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, go on check here to administer fruquintinib at advised dosage.
Applying this drugs with any of the following medicines may cause an elevated possibility of certain side effects, but employing equally drugs would be the finest procedure in your case. If the two medicines are prescribed collectively, your physician may perhaps change the dose or how frequently you utilize one or the two in the medicines.
butabarbital decreases levels of atrasentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with powerful or reasonable CYP3A inducers is anticipated to lower atrasentan systemic publicity, which may lower efficacy. .
butabarbital will reduce the level or impact of eplerenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
butabarbital will lessen the extent or result of nisoldipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
butabarbital will lower the level or outcome of estradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.